SCHEMBL17354704

SCHEMBL17354704

Cc1ccc(C(=O)Nc2cccc(-c3nc4ccccc4c(=O)o3)c2)cc1C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.78
▸ ALDH1A1 P00352 6/20 0.78
▸ MEN1 O00255 5/20 0.78
▸ POLB P06746 4/20 0.78
▸ KDM4E B2RXH2 4/20 0.78
▸ SMN1; SMN2 Q16637 2/20 0.78
▸ MAPK10 P53779 1/20 0.70
▸ TP53 P04637 3/20 0.66
▸ HPGD P15428 3/20 0.66
▸ CYP1A2 P05177 2/20 0.66
▸ CYP3A4 P08684 2/20 0.66
▸ CYP2C19 P33261 2/20 0.66
▸ NPC1 O15118 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ RAB9A P51151 1/20 0.66
▸ USP2 O75604 1/20 0.66
▸ CYP2D6 P10635 1/20 0.66
▸ GAA P10253 1/20 0.65
▸ THRB P10828 1/20 0.55
▸ MAPT P10636 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5978453 0.82 MEN1 (0.79) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL2624630 0.81 KMT2A (0.74) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL6673184 0.80 ALDH1A1 (0.76) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL19659988 0.79 MEN1 (0.74) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL27829159 0.79 ALDH1A1 (0.82) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL914359 0.78 NPC1 (0.71) KMT2AALDH1A1MEN1KDM4ESMN1; SMN2
SCHEMBL8016999 0.78 ALDH1A1 (0.73) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL692806 0.76 ALDH1A1 (0.76) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL29444198 0.76 ALDH1A1 (0.76) KMT2AALDH1A1MEN1POLBKDM4E
SCHEMBL10833831 0.75 KMT2A (0.65) KMT2AALDH1A1MEN1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216180-B2 Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay NEW YORK UNIVERSITY (US) 2015-12-22 — — US disclosed
Send feedback